$CALM

Cal-Maine Foods earnings analysis: questions answered and next catalysts

Cal-Maine Foods (CALM) reported Q1 FY2027 earnings below estimates, with revenue down 41.5% YoY and a net loss of $58.6M. Management cited oversupply in the conventional egg market and rising costs. The stock fell 3.5% premarket. Next catalysts include Q2 earnings and prepared foods capacity expansion.

Original reporting
Published Oct 1, 2026, 6:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 7:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CALM
Bearish
high confidence
Mentioned
$CALM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CALMBearishHigh
01

Why it matters

The miss underscores supply oversupply and cost pressures, suggesting near‑term downside but possible medium‑term recovery.

02

Market read

Earnings miss drives immediate price decline and may influence related agribusiness stocks.

03

What to watch

Potential upside from lower commodity exposure and upcoming capacity expansion in FY2028.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Cal-Maine Foods is the largest U.S. egg producer; its earnings are a bellwether for the commodity egg market.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine Foods reported FY2027 Q1 earnings miss: EPS -$1.26 vs -$0.47 estimate and revenue $539.6M vs $587.8M.

Expected impact

likely pressure as the market prices in the earnings miss and lowered guidance.

Evidence & confidence

The company posted a large loss and missed both EPS and revenue expectations, prompting a 3.5% pre‑market decline.

Market effects

Egg and prepared‑foods sector may see broader scrutiny as supply‑driven pressures emerge.

U.S. agribusiness stocks could face short‑term weakness.

Limited to U.S. consumer‑staples and agricultural commodity markets.

Counterpoint

If the prepared‑foods ramp succeeds, the miss could be temporary and the stock may be undervalued.

Key entities

  • Cal-Maine Foods

    U.S. egg producer (ticker CALM).

Related articles

$CALMMed

Maybe There Was an Egg Cartel After All

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

$FRPTMed

Perishable Food Q2 Earnings: Mission Produce (NASDAQ:AVO) is the Best in the Biz

Freshpet (FRPT) reported Q2 revenue of $305.6M, up 15.5% YoY, beating estimates. Cal-Maine (CALM) saw revenue drop 41.5% YoY to $539.6M, missing expectations. Pilgrim's Pride (PPC) reported $4.63B revenue, down 2.8% YoY, also missing estimates. United Natural Foods (UNFI) reported flat revenue at $7.64B, slightly missing expectations. All stocks except UNFI are down since reporting.

$CALMMed

Cal-Maine Foods (CALM), Why Is It Back In Focus Today?

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

$CALMMedAI 8/10

Is Cal-Maine’s (CALM) Egg Slump Already Priced Into the Stock?

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.

$CALMMed

Will Wider Quarterly Loss Change Cal Maine Foods' (CALM) Narrative

Cal-Maine Foods reported Q1 2027 sales of $539.61M and a net loss of $58.62M, both down year-over-year. Lower demand and pricing for conventional shell eggs impacted profitability, leading to a suspended dividend. The company continued share repurchases and rolled out Amino to improve data flows, focusing on operational efficiency. Investors now assess the impact of these results on the company's investment narrative, with a P/E of 53x and execution risks highlighted.

$CALMHigh

Egg prices are falling, and the nation’s top producer is paying the price

Cal-Maine Foods Inc. reported a 42% drop in net sales for its fiscal first quarter, with prices falling due to oversupply. The company posted a $59 million net loss. Shares fell 7.4%. According to the US Bureau of Labor Statistics, large grade A shell eggs averaged $2.272 a dozen in August. The company will not pay a cash dividend. U.S. egg output and laying flock increased year-over-year in August, but egg chicks placed for future hatchery supplies dropped 7%.